Simpler Grants.gov #RFA-DA-27-002

NIDA Seeks Research Sites for Continued Adolescent Brain Cognitive Development (ABCD) Study

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is seeking applications for research project sites to continue the Adolescent Brain Cognitive Development (ABCD) Study. - Government Buyer: - National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) - Project Scope: - Continue longitudinal research on nearly 12,000 participants from the ABCD cohort into adulthood - Study outcomes include substance use disorders, mental health disorders, chronic diseases, and other health conditions - Utilize advanced technologies such as brain scans and wearable sensors to collect data on brain development and health outcomes - Eligibility: - Only organizations previously funded under RFA-DA-20-002 are eligible to apply - Funding Instrument: - Cooperative agreement (not a standard contract or grant) - Products/Services: - No specific OEMs, vendors, or product part numbers are mentioned - Main service is the operation of research project sites for the ABCD Study - Unique Requirements: - Focus on following the same cohort into emerging adulthood - Emphasis on advanced data collection methods (e.g., neuroimaging, wearable technology) - Restricted competition to prior awardees

Description

The National Institute on Drug Abuse (NIDA), with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the research sites for the Adolescent Brain Cognitive Development (ABCD) Study. The ABCD study is the largest long-term study of brain development and child and adolescent health in the United States. This renewal will continue to follow the ABCD cohort into adulthood, when many of the outcomes of interest (e.g., substance use disorders, mental health disorders, chronic diseases, and other health conditions) will manifest. The ABCD Study has been highly successful in recruiting a cohort of almost 12,000 participants beginning at ages 9-10 and assessing them to ages 19-20. This proposed renewal would follow these children for five years through their emerging adulthood. By using cutting-edge technology such as brain scans and wearable sensors, scientists have an unprecedented opportunity to determine how young adult experiences interact with biology to affect outcomes.

View original listing